Continuous Disclosure Policy

Healthscope is committed to the provision of timely, full and accurate disclosure to the market.

This Policy aims to ensure compliance with the continuous disclosure obligations under the Corporations Act and Australian Stock Exchange (ASX) Listing Rules, such that:

All investors have equal and timely access to material information concerning Healthscope – including its financial situation, performance, ownership and governance; and
Company announcements are factual and presented in a clear and balanced way.

The Policy puts in place vetting and authorisation processes designed to ensure that company announcements are made in a timely manner, are factual, do not omit material information and are expressed in a clear and objective manner.

Disclosure of material information

Healthscope will immediately notify the ASX of any material information concerning Healthscope in accordance with regulatory requirements.

“Material information” in this Policy means any information concerning Healthscope, which a reasonable person would expect to have material effect on the price or value of any securities issued by Healthscope. A reasonable person would be taken to expect information to have a material effect on the price of Healthscope securities if that information would, or would be likely to, influence investors in deciding whether to buy, hold or sell Healthscope securities.

Exceptions

In accordance with ASX Listing Rule 3.1, Healthscope is not required to disclose material information about the Company if:

A reasonable person would not expect the information to be disclosed; and
The information is confidential (and the ASX has not formed the view that the information has ceased to be confidential; and
The information is of a kind which is exempted by Listing Rule 3.1 (for example, where the information is insufficiently definite to warrant disclosure, concerns an incomplete negotiation or proposal, is generated for internal management purposes, or its disclosure would breach the law).

Responsibilities for disclosure

Healthscope has designated the Managing Director and Chief Financial Officer as “Disclosure Officers”.

Healthscope’s Disclosure Officers have responsibility for reviewing proposed disclosures and making decisions in relation to what information can or should be disclosed to the market.

All Healthscope staff are required to inform a Disclosure Officer of any potentially material information concerning the Company as soon as they become aware of it. If staff are unsure whether information is potentially material, they may discuss the matter with their divisional Chief Operating Officer or a Disclosure Officer.

The Company Secretary is responsible for:

Overseeing and coordinating disclosure of material information to the ASX;
Communicating and promoting understanding of this Policy to Healthscope’s Disclosure Officers;
Providing advice on disclosure of material information, which may include obtaining external legal advice;
Ensuring all Company releases to the ASX are promptly posted on Healthscope’s website;
Reviewing this Policy, at least annually, to ensure continued compliance with the Corporations Act and ASX Listing Rules.

Market Speculation

Healthscope will not generally respond to market speculation and rumours unless required to do so by law or the ASX, for example, in order to prevent a false market in Healthscope’s securities. If necessary, Healthscope may request a trading halt in order to prevent trading in Healthscope securities in a false or uninformed market.

External Communication

Other than Healthscope’s Disclosure Officers, no employee can speak on behalf of Healthscope to media, analysts or investors, unless specifically authorised by the Managing Director.

Healthscope will not publicly disclose material information before formally disclosing the information to the ASX.

If material information is provided to analysts, the media or other external parties without first being disclosed to ASX, the Company Secretary should be notified of the disclosure immediately, and the Company Secretary will then arrange for disclosure in accordance with this Policy.

Last Reviewed: August 2009



	Home Company Profile Board of Directors Environmental Policy Exec Team Profiles Investor Centre Acquisition Proposal Corporate Governance Shareholder Information ASX Announcements Annual Reports Half Yearly Reports Presentations Corporate Calendar Share Registry Information Careers Search Current Positions Graduate Nurses International Nurses Bringing Nurses Back Into the Workforce Communications The Pulse Health Matters Contact Us
Healthscope Hospitals Medical Centres GP Clinics Skin Clinics Community Programs Human Pathology Advanced Pathology Veterinary Pathology Australia New Zealand Commercial Pathology Functional Pathology	Continuous Disclosure Policy Healthscope is committed to the provision of timely, full and accurate disclosure to the market. This Policy aims to ensure compliance with the continuous disclosure obligations under the Corporations Act and Australian Stock Exchange (ASX) Listing Rules, such that: All investors have equal and timely access to material information concerning Healthscope – including its financial situation, performance, ownership and governance; and Company announcements are factual and presented in a clear and balanced way. The Policy puts in place vetting and authorisation processes designed to ensure that company announcements are made in a timely manner, are factual, do not omit material information and are expressed in a clear and objective manner. Disclosure of material information Healthscope will immediately notify the ASX of any material information concerning Healthscope in accordance with regulatory requirements. “Material information” in this Policy means any information concerning Healthscope, which a reasonable person would expect to have material effect on the price or value of any securities issued by Healthscope. A reasonable person would be taken to expect information to have a material effect on the price of Healthscope securities if that information would, or would be likely to, influence investors in deciding whether to buy, hold or sell Healthscope securities. Exceptions In accordance with ASX Listing Rule 3.1, Healthscope is not required to disclose material information about the Company if: A reasonable person would not expect the information to be disclosed; and The information is confidential (and the ASX has not formed the view that the information has ceased to be confidential; and The information is of a kind which is exempted by Listing Rule 3.1 (for example, where the information is insufficiently definite to warrant disclosure, concerns an incomplete negotiation or proposal, is generated for internal management purposes, or its disclosure would breach the law). Responsibilities for disclosure Healthscope has designated the Managing Director and Chief Financial Officer as “Disclosure Officers”. Healthscope’s Disclosure Officers have responsibility for reviewing proposed disclosures and making decisions in relation to what information can or should be disclosed to the market. All Healthscope staff are required to inform a Disclosure Officer of any potentially material information concerning the Company as soon as they become aware of it. If staff are unsure whether information is potentially material, they may discuss the matter with their divisional Chief Operating Officer or a Disclosure Officer. The Company Secretary is responsible for: Overseeing and coordinating disclosure of material information to the ASX; Communicating and promoting understanding of this Policy to Healthscope’s Disclosure Officers; Providing advice on disclosure of material information, which may include obtaining external legal advice; Ensuring all Company releases to the ASX are promptly posted on Healthscope’s website; Reviewing this Policy, at least annually, to ensure continued compliance with the Corporations Act and ASX Listing Rules. Market Speculation Healthscope will not generally respond to market speculation and rumours unless required to do so by law or the ASX, for example, in order to prevent a false market in Healthscope’s securities. If necessary, Healthscope may request a trading halt in order to prevent trading in Healthscope securities in a false or uninformed market. External Communication Other than Healthscope’s Disclosure Officers, no employee can speak on behalf of Healthscope to media, analysts or investors, unless specifically authorised by the Managing Director. Healthscope will not publicly disclose material information before formally disclosing the information to the ASX. If material information is provided to analysts, the media or other external parties without first being disclosed to ASX, the Company Secretary should be notified of the disclosure immediately, and the Company Secretary will then arrange for disclosure in accordance with this Policy. Last Reviewed: August 2009
	Privacy Policy \| Contact Us Copyright Š2009 Healthscope Limited - All Rights Reserved